Insero starts operations with IP from Harvard
Insero Health Inc. (naturally derived therapeutics) is starting operations with an exclusive license to key patents from Harvard University pertaining to the start-up’s lead preclinical CNS candidate huperzine.
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.